| No headlines available for FACTX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
113.81M |
| Category: |
Health |
| Total Expense Ratio: |
1.49% |
|
| PERFORMANCE & RISK | 31-Jan-10
| YTD Return: |
0.42% |
| 5y Avg Return: |
4.09% |
| Rank in Category (ytd): |
43 |
| % Rank in Category (ytd): |
25.9% |
| Beta (3y): |
0.82 |
| Morningstar Risk Rating: |
Average |
|
| The investment seeks capital appreciation. The fund normally invests at least 80% of assets in companies engaged in the design, manufacture, or sale of products or services used for or in connection with healthcare or medicine. These may include pharmaceutical companies, companies involved in research and development, and companies involved in healthcare facilities. It is nondiversified. |
|
| Fund Profile |
|
Help
0.15 (0.80%) 
Summary
Add FACTX to Portfolio 
Download Data
